Dr. Jasmine Plummer of St. Jude Children’s Research Hospital (formerly of Cedars-Sinai Medical Center) is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on better understanding how genetic mutations trigger cancer development. The goal of her research is to find early biomarkers of ovarian cancer and also identify drugs to effectively … Continued
Many brides count their wedding day as one of the most momentous occasions in their life. And now they have a way to make this milestone even more meaningful long after they have exchanged vows – all thanks to a team of OCRA Heroes who have raised funds for Ovarian Cancer Research Alliance by reselling … Continued
Madeleine and Emma Jean may be young, at ages eight and nine, respectively, but they are already focused on how to help create a future in which no families are impacted by ovarian cancer. These two OCRA Heroes have never met but they have a shared motivation for their efforts — losing their namesakes to … Continued
Dr. Benjamin Bitler of the University of Colorado is a 2022 recipient of OCRA’s Collaborative Research Development Grant. His OCRA-funded project, which is expanding on findings from the Ovarian Cancer Research Group at the University of Colorado, aims to harness cutting-edge molecular profiling and advanced computational analysis in order to predict ovarian cancer recurrence and provide … Continued
Diagnosed with ovarian cancer in 2022, Marsha Biven currently participates in a number of OCRA programs, including Staying Connected, Survivors Teaching Students, and Woman to Woman. Read on to learn more about her story, including how a vision board (and a rogue parakeet!) factored into her experience and why her professional background is an asset … Continued
Three cheers for a collegiate group of OCRA Heroes who have put in time and energy to raise critical funds for ovarian cancer research. A field hockey team, a pharmaceutical fraternity, and a management class student all showed up and showed their support for our community in separate efforts over the past year. Read on … Continued
Two OCRA Heroes are committed to pushing the limits of their physical endurance as a show of solidarity for our community this spring. Ethan Willey from Arizona and Mark Everitt from Connecticut will be taking on swimming, biking and running in order to complete a daunting 70.3 miles during two separate Half Ironman events — … Continued
Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancer,” Dr. Brodeur is investigating a genetic mutation, found in more than half of ovarian cancers, that is associated with relatively high presence of active immune … Continued
Dr. Amrita Salvi, of University of Illinois at Chicago, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Investigating the Mechanism of Action of PHY34 in HGSOC,” Dr. Salvi is exploring the potential of a synthetic molecule called PHY34, which has been shown to reduce ovarian tumor growth in mice models, for … Continued
Dr. Zelei Yang, of Dana Farber Cancer Institute, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer,” Dr. Yang is investigating a potential new immune therapy for ovarian cancer, by focusing on BRD1 protein inhibitors that hold potential to trigger a person’s immune system … Continued
Dr. Gamze Bildik Elcik, postdoctoral fellow in the Department of Experimental Therapeutics at MD Anderson Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “DIRAS3 Inhibits KRAS and Sensitizes LGSOC Cells to Anti-autophagic Therapy,” Dr. Bildik Elcik aims to address the issue of chemotherapy resistance in a large subset of … Continued
Ie-Ming Shih, MD, PhD is on a quest to better understand the human condition. He is a pathologist who studies human tissue to learn more about the origins of ovarian cancer; a Distinguished Professor (Endowed Chair) of Gynecologic Pathology who directs that research program at the Johns Hopkins University School of Medicine; the co-director of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
